Job Opportunities for Indian Life Scientists

As many of you may know, I attend national science meetings where I offer resume critiquing services and give career development seminars on topics ranging from resume writing to alternate career opportunities for life scientists. Frequently, I critique the resumes of foreign PhD students and postdocs who want remain in the US but cannot for a variety of reasons related to visa status. I usually tell them that there are more job opportunities for them in their home countries; usually India and China, than there are in the US which no longer has a great demand for R&D scientists

Until recently, I hadn’t heard of any Asian recruiting firms or organizations that would help to find jobs for US-trained life scientists. Much to my surprise, I heard from Shyam Suryanarayanan, an entrepreneur who started a recruiting organization called ABLE C-Drive that helps place US-trained Indian nationals into life science jobs at Indian pharmaceutical and biotechnology companies.   I asked Shyam to send me a description of the services offered by ABLE C-Drive. Here is what he wrote:

"ABLE C-DRIVE (www.cdrivejobs.com) is a specialist Life Science Career Platform for the Indian Life Science Industry.  It is an initiative launched by C-DRIVE ( a specialist Life Science Career Solutions Company), in collaboration with ABLE - (Association of Biotechnology Led Enterprises), the Industry Association and the face of the Indian Biotech sector. The company is a pioneering initiative in the Indian Life Science Careers space to help Life Science Professionals be accessible/visible to a whole host of hiring organizations in a discreet manner, with a view to getting hired.  The 'Returning Indian' Community is a preferred group, given their strong training and experience in World Class research labs.

The list of companies hiring from this platform includes a mix of large global home grown leaders, as well as exciting small and medium-sized outfits across pharma, biotech, agricultural sciences (nutraceuticals), bioinformatics, clinical research, contract research and manufacturing." 

Our platform is a boon to hiring companies, because it is a single destination for pre-screened, quality life science professionals which significantly lower the cost, time and effort required for hiring. For additional information, please visit www.cdrivejobs.com or send your resume to lifejobs@cdrivecareers.com

Those of you who are seeking life sciences jobs in India ought to check ABLE-C Drive out!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

 SocialTwist Tell-a-Friend

Going, Going....Gone: Genentech Agrees to Roche Buyout

Late Thursday, after 8 months of difficult and often acrimonious negotiations, Genentech’s board finally caved and agreed to allow Roche to purchase the remaining 44% of the outstanding Genentech shares that it doesn’t already own. The price: $95 per share—less than the $112 per share that Genentech’s board and management team wanted —but better than the $86.50 per share that was tendered last fall.

While Roche contends that it will continue to run Genentech as an autonomously operating business unit, many Genentech employees are dubious. I suspect that many DNA (Genentech’s stock symbol) employees will embrace a “wait and see” attitude before any decisions are made about whether or not to stay at the “new company.” Roche’s greatest challenge will be integrating the two companies without ruining Genentech’s innovative culture and immediately sending its best scientists and management team out the door. Pharma and biotech corporate cultures are very different from one another and many biotech employees find it difficult to adapt to big pharma’s slow-moving and anachronistic approach to drug development. As previously reported, US business operations of both companies will be based at Genentech’s headquarters in South San Francisco, CA rather than in Nutley, NJ, where Roche’s American business is currently based. This is not good news for many of Roche’s Nutley employees. Roche has been trying unsuccessfully for years to jettison the Nutley site and it seems likely now. Don’t be surprised if you see a mass exodus at the Nutley site. All of Roche’s US products will be sold under the Genentech brand.

Roche’s purchase of Genentech, America’s oldest biotechnology company (started in 1976) and considered by many to be the crown jewel of the industry, truly signals the end of an era. Let’s hope that another “Genentech” (and others like it) emerge as the US biotechnology industry continues to evolve in the 21st century.

Until next time...

Good Luck and Good Job Hunting!!!!!

 

SocialTwist Tell-a-Friend